Tet2 null mice develop many hematopoietic abnormalities with myeloid proliferative neoplasms and chronic lymphocytic leukemia, hinting that Tet2 is also a tumor suppressor in hematopoietic tissue. Here, TET2 is linked to B-cell chronic lymphocytic leukemia.